# Intraurethral Lidocaine After Endourology Procedures

> **NCT03537534** · PHASE3 · TERMINATED · sponsor: **San Antonio Uniformed Services Health Education Consortium** · enrollment: 35 (actual)

## Conditions studied

- Dysuria

## Interventions

- **DRUG:** Lidocaine Jet Injector
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT03537534
- **Lead sponsor:** San Antonio Uniformed Services Health Education Consortium
- **Sponsor class:** FED
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-04-15
- **Primary completion:** 2022-09-01
- **Final completion:** 2022-09-01
- **Target enrollment:** 35 (ACTUAL)
- **Why stopped:** Lack of enrollment
- **Last updated:** 2024-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03537534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03537534, "Intraurethral Lidocaine After Endourology Procedures". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03537534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*